Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis - From laboratory parameters to clinical scores

British Journal of Dermatology

Volumn 154, Issue 6, 2006, Pages 1112-1117

  Angelova Fischer, I ^a   Hipler, U C ^b   Bauer, A ^b   Fluhr, J W ^b   Tsankov, N ^a   Fischer, T W ^b   Elsner, P ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Atopic dermatitis; Disease activity; Eosinophil cationic protein (ECP); Interleukin 16; Macrophage derived chemokine (MDC); Soluble E selectin (sE selectin)

Indexed keywords

BIOCHEMICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOSINOPHIL CATIONIC PROTEIN; INTERLEUKIN 16; MACROPHAGE DERIVED CHEMOKINE;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL LABORATORY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HELPER CELL; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; MALE; MONITORING; PATHOGENESIS; PRIORITY JOURNAL; SCORING SYSTEM;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHEMOKINES, CC; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; E-SELECTIN; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HUMANS; INTERLEUKIN-16; MALE; SEVERITY OF ILLNESS INDEX;

EID: 33646566000     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07201.x     Document Type: Article

References (38)

1. Kägi M Joller-Jemelka H Wüthrich B Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis Dermatology 1992 185 88 92
2. Wolkerstorfer A Laan MP Savelkoul HFJ et al. Soluble E-selectin, other markers of inflammation and disease severity in children with atopic dermatitis Br J Dermatol 1998 138 431 5
3. Hijnen D Bruin-Weller M Oosting B et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T-cell attracting chemokine (CTACK) levels in allergic diseases J Allergy Clin Immunol 2004 113 334 40
4. Toyoda M Nakamura M Makino T et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis Br J Dermatol 2002 147 71 9
5. Folster-Holst R Henseler T Wehde J et al. Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis Acta Derm Venereol 2002 82 245 8
6. Charman C Williams HC Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring J Invest Dermatol 2003 120 932 41
7. Williams H 'Objective' measures of atopic dermatitis severity Arch Dermatol 2003 139 1490 2
8. Severity scoring of atopic dermatitis: the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis Dermatology 1993 186 23 31
9. Kunz B Oranje A Labreze L et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis Dermatology 1997 195 10 19
10. Hanifin JM Rajka G Diagnostic features of atopic dermatitis Acta Derm Venereol 1980 92 Suppl. 44 7
11. Diepgen TL Sauerbrei W Fartasch M Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness J Clin Epidemiol 1996 49 1031 8
12. Center D Cruikshank W Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells J Immunol 1982 128 2563 8
13. Center D Cruikshank W Modulation of lymphocyte migration by human lymphokines. II. Purification of lymphotactic factor (LCF) J Immunol 1982 128 2569 71
14. Cruikshank W Berman J Theodore A et al. Lymphokine activation of T4+ lymphocytes and monocytes J Immunol 1987 138 3817 23
15. Lim K Wan H-C Bozza P Resnick M Human eosinophils elaborate the lymphocyte chemoattractants: IL-16 (lymphocyte chemoattractant factor) and RANTES J Immunol 1996 156 2566 70
16. Rand T Cruikshank W Center D et al. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration J Exp Med 1991 173 1521 8
17. Kaser A Dunzendorfer S Offner F et al. A role for IL-16 in the cross-talk between dendritic cells and T cells J Immunol 1999 163 3232 8
18. Liu Y Cruikshank W O'Loughlin T et al. Identification of a CD4 domain required for IL-16 binding and lymphocyte activation J Biol Chem 1999 274 23387 95
19. Cruikshank W Kornfeld H Center D Interleukin-16 J Leukoc Biol 2000 67 757 66
20. Laberge S Cruikshank W Kornfeld H et al. Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro J Immunol 1996 156 310 15
21. Laberge S Cruikshank W Kornfeld H et al. Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ T cells is independent of transcription and translation: evidence for constitutive protein synthesis and storage J Immunol 1995 55 2902 10
22. Wu D Zhang Y Parada N et al. Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent J Immunol 1999 162 1287 93
23. Rumsaeng V Cruikshank W Foster B et al. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16 J Immunol 1997 159 2904 10
24. Bellini A Yoshimura H Vitori E et al. Bronchial epithelial cells of patients with asthma release chemoattractants for T lymphocytes J Allergy Clin Immunol 1993 92 412 24
25. Arima M Plitt J Stellato C et al. The expression of lymphocyte chemoattractant factor (LCF) in human bronchial epithelial cells J Allergy Clin Immunol 1995 97 293A
26. Taha R Laberge S Hamid Q Olivenstein R Increased expression of the chemoattractant cytokines eotaxin, monocyte chemotactic protein-4, and interleukin-16 in induced sputum in asthmatic patients Chest 2001 120 595 601
27. Laberge S Ghaffar O Boguniewicz M et al. Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis J Allergy Clin Immunol 1998 102 645 50
28. Frezzolini A Paradisi M Zaffiro A et al. Circulating interleukin 16 (IL-16) in children with atopic eczema/dermatitis syndrome (AEDS): a novel serological marker of disease activity Allergy 2002 57 815 20
29. Masuda K Katoh N Okuda F Kishimoto S Increased levels of serum interleukin-16 in adult type atopic dermatitis Acta Derm Venereol 2003 83 249 53
30. Costa C Rilliet A Nicolet M Saurat JH Scoring atopic dermatitis: the simpler the better Acta Derm Venereol 1989 69 41 5
31. Kakinuma T Nakamura K Wakugawa M et al. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis Clin Exp Immunol 2002 127 270 3
32. Fujisawa T Fujisawa R Kato Y et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis J Allergy Clin Immunol 2002 110 139 46
33. Jahnz-Rozyk K Targowski T Paluchowska E et al. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis Allergy 2005 60 685 8
34. Gebhardt M Wenzel HC Hipler UC et al. Monitoring serologic immune parameters in inflammatory skin diseases Allergy 1997 52 1087 94
35. Pucci N Novembre E Cammarata MG et al. Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index Allergy 2005 60 113 16
36. Elias P Wood L Feingold K Epidermal pathogenesis of inflammatory dermatoses Am J Contact Dermat 1999 10 119 26
37. Wood L Jackson P Elias P et al. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice J Clin Invest 1992 90 482 7
38. Nickoloff B Naidu Y Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin J Am Acad Dermatol 1994 30 535 46